ACP Regulatory News
CMS Releases Prior Authorization Final Rule Requiring Payers to Provide Decisions Within Three to Seven Days
ACP believes the required time frame should be even shorter; is advocating for legislation that would advance reforms directly impacting prior authorization processes.
ACP Calls for CMS to Ensure Network Adequacy in the ACA Proposed Rule for 2025
Says plans through the Marketplaces should meet network adequacy requirements to ensure services are accessible without unreasonable delay.
Advocacy in Action
ACP Unveils Federal Advocacy Priority List for 2024
Some priorities include physician payment reform, reducing administrative burden and strengthening the physician workforce.
In Case You Missed It
ACP is calling on internal medicine physicians to contact your members of Congress to ask them to support the Improving Seniors Timely Access to Care Act and the Safe Step Act. The Improving Seniors Timely Access to Care Act would further streamline prior authorization for Medicare Advantage plans. The Safe Step Act would require group health plans to provide an exception process to any medication step therapy protocol.
Visit ACP's to learn more and to take action. A sample email message is provided for you that includes space for you to personalize the letter.
ACP is calling on internal medicine physicians to contact your members of Congress to ask them to support the Conrad State 30 and Physician Access Reauthorization Act. The Conrad 30 waiver program allows states to request J-1 visa waivers for 30 foreign physicians per state, per year to work in federally designated shortage areas. Reauthorizing and strengthening the program is one policy solution to help alleviate the physician shortage.
Visit ACP's to learn more and to take action. A sample email message is provided for you that includes space for you to personalize the letter.
Advocacy News From ACP
Novartis Pharmaceuticals Corp., v. Novo Nordisk, Inc., et al., v. Xavier Becerra, U.S. Secretary of Health & Human Services, et al.
In this amicus brief, the interested parties argue that America's unsustainably high prescription drug pricing has substantial and escalating negative impacts on public health and patient outcomes.
Jaime Masters; Texas Department of Family and Protective Services, v. PFLAG, Inc; Mirabel Voe and Antonio Voe, a minor; Wanda Roe and Tommy Roe, a minor; Adam Briggle and Amber Briggle and M.B., a minor
In this amicus brief, the interested parties argue that enforcement of a Texas directive to investigate gender-affirming care as child abuse would irreparably harm many adolescents by denying them the treatment they need.
ACP Advocate is copyrighted ©2024 by the Ñî¹óåú´«Ã½.